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Background: We aimed to explore the American College of Rheumatology (ACR) 1990 and 2011 fibromyalgia 
(FM) classification criteria’s items and the components of Fibromyalgia Impact Questionnaire (FIQ) to identify 
features best discriminating FM features. Finally, we developed a combined FM diagnostic (C-FM) model using 
the FM’s key features.
Methods: The means and frequency on tender points (TPs), ACR 2011 components and FIQ items were 
calculated in the FM and non-FM (osteoarthritis [OA] and non-OA) patients. Then, two-step multiple logistic 
regression analysis was performed to order these variables according to their maximal statistical contribution 
in predicting group membership. Partial correlations assessed their unique contribution, and two-group dis-
criminant analysis provided a classification table. Using receiver operator characteristic analyses, we determined 
the sensitivity and specificity of the final model.
Results: A total of 172 patients with FM, 75 with OA and 21 with periarthritis or regional pain syndromes 
were enrolled. Two steps multiple logistic regression analysis identified 8 key features of FM which accounted 
for 64.8% of variance associated with FM group membership: lateral epicondyle TP with variance percentages 
(36.9%), neck pain (14.5%), fatigue (4.7%), insomnia (3%), upper back pain (2.2%), shoulder pain (1.5%), 
gluteal TP (1.2%), and FIQ fatigue (0.9%). The C-FM model demonstrated a 91.4% correct classification rate, 
91.9% for sensitivity and 91.7% for specificity. 
Conclusions: The C-FM model can accurately detect FM patients among other pain disorders. Re-inclusion 
of TPs along with saving of FM main symptoms in the C-FM model is a unique feature of this model. (Korean 
J Pain 2019; 32: 120-8)
Key Words: Chronic pain; Discriminant analysis; Fatigue; Fibromyalgia; Logistic models; Neck pain; 
Osteoarthritis; Periarthritis; Sensitivity and specificity; Shoulder pain; Sleep initiation and maintenance 
disorders; Survey and questionnaires.
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INTRODUCTION
Fibromyalgia (FM) is often considered as part of a diverse 
spectrum of heterogeneous symptoms that lack precise 
classification [1,2]. Over the last 4 decades, much effort 
has been made to recognize the best discriminative set of 
FM diagnostic criteria. However, the FM criteria have un-
dergone numerous revisions since first reported [3]. For a 
long period of time the mainstay of FM diagnosis was the 
American College of Rheumatology (ACR) 1990 FM classi-
fication criteria which was based on the presence of wide-
spread pain and tender points (TPs) on examination [4]. 
But the examination of TPs did not address FM symptoms 
and was hard to perform for most non-rheumatologists 
[5-7].
The ACR 2010 criteria [6] and its self-reported ver-
sion, the modified ACR 2011 criteria [7] not only eliminated 
TPs, but also changed the case definition of FM to an ill-
ness characterized by self-reported, multiple painful re-
gions and additional key symptoms, such as problems with 
fatigue, sleep, cognition, and the extent of somatic symp-
tom reporting. The modification to the ACR 2010 diag-
nostic criteria was to substitute a count of 3 symptoms 
(headache, pain or cramps in lower abdomen, and depres-
sion symptoms) for the physician’s evaluation of the extent 
of somatic symptom intensity (a score of 0-3). The modi-
fied 2011 criteria allow for clinical research without requir-
ing an examiner interview [7].
Although these criteria have incorporated the most 
core symptoms of FM, it seems that a diagnostic approach 
of the disease which is only symptom-based has been 
subject to criticism from the very beginning [8,9]. Percep-
tions of physicians and patients might differ in their as-
sessment of symptom severity due to the substantial sub-
jectivity of criteria items [5-7]. Dropping the TPs or hy-
peralgesia concept as the only semi-objective finding in 
FM is not only the main advantage of the ACR 2010 criteria 
but also their greatest drawback [8,10]. Although many FM 
experts believe that TPs’ examination and interpretation 
is difficult and may not be a valid or reliable finding in clin-
ical settings [6], there are still some valid concerns that 
totally abandoning the TP concept would omit examination 
of the distinctive ‘hyperalgesia aspect’ of FM [11]. 
To the best of our knowledge, there has been no effort 
to extract and combine the best discriminative items of the 
existing FM diagnostic criteria. Undoubtedly, each set of 
diagnostic criteria has valuable properties which can be 
useful in correct final diagnosis. A combination of the ACR 
criteria (1990, 2011) seems to be able, at least partially, 
to address the mentioned disadvantages of each criteria. 
Moreover, the fibromyalgia impact questionnaire (FIQ) is 
another disease-specific composite measure which has 
some diagnostic properties for FM [12]. It has some differ-
ent items in comparison to the ACR criteria, and measure 
different aspects of FM impact, such as functional status 
[12,13]. 
The objective of the current study was to explore the 
ACR 1990 and 2011 classification criteria items and the FIQ 
components to identify the best discriminative features of 
FM, or “FM key features.” Furthermore, we set out to pro-
vide a combined FM diagnostic (C-FM) model embracing 
the FM key features which can accurately identify FM pa-
tients among non-FM chronic pain disorders patients.
MATERIALS AND METHODS
1. Study patients 
Data regarding a total of 172 FM and 96 non-FM chronic 
pain (control) patients were taken from an existing FM da-
tabank [14,15]. This FM databank included patients who 
had been seen at six rheumatologic clinics including two 
teaching rheumatology clinics (Hazrat-e-Rasoul Akram 
General Hospital, a teaching hospital of Iran University of 
Medical Sciences [IUMS], and Razi General Hospital, a 
teaching hospital of Guilan University of Medical Sciences 
[GUMS]), three private rheumatology clinics and the 
Iranian Center for Medical Laser (ICML) affilated to 
Academic Center for Education, Culture and Research. We 
designed this study among female subjects in order to 
avoid if any confounding factors. 
The recruitment of patients was done from September 
2011 to August 2015 by three rheumatologists selected by 
the author (BGP, AB, AH) who were experienced in the di-
agnosis and management of chronic pain and FM. FM di-
agnoses in this databank were based on clinical grounds 
and the physician’s experience, not any the ACR criteria. 
So, it was not a requirement of diagnosis to have satisfied 
the ACR 1990 or 2010 criteria. The chronic pain control 
group included age-matched females with a painful non-
inflammatory rheumatic condition such as osteoarthritis 
(OA), periarthritis, or regional pain syndromes. Regional 
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pain syndrome included the patients with a diagnosis of 
non-specific low back pain, neck pain, myofascial pain or 
tendinitis (such as lateral or medial epicondylitis, adhesive 
capsulitis, etc.) They did not have a concurrent diagnosis 
of FM at the time of enrollment. We divided the control 
group into OA (75 patients) and non-OA (21 patients) sub-
groups; the non-OA subgroup included patients with peri-
arthritis or regional pain syndromes. Patients with any in-
flammatory rheumatic disorder, active cancer, fractures, 
other nonrheumatic causes for pain, and inability to read 
or write were excluded from the study. 
This study was approved by the Ethics Committee of 
Guilan University of Medical Sciences. All patients signed 
the informed consent form.
2. Instruments (ACR 1990 and 2011 classification criteria 
and FIQ) 
We compared the ACR 1990 and 2011 classification criteria 
items as well as FIQ components between the FM and 
non-FM control groups. As the widespread pain criterion 
(4-quadrant pain plus axial pain) in the ACR 1990 criteria 
is conceptually similar to the widespread pain index (WPI) 
in the ACR 2011 criteria, we chose 19 painful regions of 
WPI as the indicators of pain locations to compare FM and 
non-FM patients. Data regarding dolorimetric assessment 
of 18 defined TPs in FM and non-FM patients were col-
lected from our databank. The pressure pain threshold was 
defined as the minimum force applied to induce pain. 
Mechanical pressure of each defined anatomical location 
was measured using a dolorimeter (Force Dial
TM
 FDK20, 
Wagner Instrument, Greenwich, CT) and reported as 
kg/cm
2
 of the skin [4]. The measured pain threshold in 
each site was recorded as its TP score.
The ACR 2011 classification criteria consist of two 
components: WPI (19 defined pain sites) and symptom se-
verity score (6 major FM symptoms) [7,15]. We collected 
the results of 19 pain locations and 6 major FM symptoms 
evaluated in all participants, and compared FM and 
non-FM patients according to them. Furthermore, we 
added insomnia and memory disturbance (thinking or re-
membering problems) as dichotomous questions to our 
analysis. These two symptoms were part of the original 
ACR 2010 criteria but were later omitted in the modified 
2011 criteria. It seems insomnia and memory disturbance 
have diagnostic importance and can be surrogate symp-
toms for waking unrefreshed and cognitive symptoms, re-
spectively [6].
The FIQ was the other tool used in this study consid-
ering its diagnostic utility in differentiating FM from non- 
FM [12,16]. The FIQ is a disease-specific composite meas-
ure composed of 10 questions [12]. We assessed all ques-
tions (20 items) in FM and non-FM patients to identify the 
most discriminative items between the two groups.
3. Statistical analyses
Descriptive statistics were used to report frequencies and 
scores. The means and frequency comparing FM and 
non-FM patients (OA and non-OA pain groups) on TPs 
scores, ACR 2011 components (pain locations and major 
FM symptoms) and FIQ items were calculated. Then, multi-
ple regression analysis was done to identify the significant 
predictors of FM membership. First, the standard multiple 
regression analysis was done to reduce the number of 
variables. Actually, this stage of regression analysis iden-
tified the significant and unique predictors of group mem-
bership, thereby reducing the number of variables from 67 
to 20. For the sake of preventing variable loss, we kept 
variables with a P value of less than 0.3 in the initial 
model. The stepwise multiple regression analysis was then 
performed to order the identified variables according to 
their maximal statistical contribution in predicting FM ver-
sus non-FM membership. The final regression analysis 
model retained 8 significant variables which had best pre-
dicted FM membership. Then, the partial correlation anal-
ysis assessed the unique contribution of predictors, and 
the two-group discriminant analysis provided a classi-
fication table. Finally, the receiver operator characteristic 
(ROC) and area under the curve analyses were used to de-
termine the sensitivity and specificity of the final model. 
RESULTS
All patients were female with the mean ± standard devia-
tion age of 43 ± 11 years in FM patients and 47 ± 11 years 
in non-FM chronic pain patients. There were no statistical 
differences in habitancy between the FM and non-FM 
groups (P = 0.6). FM patients were different in marital sta-
tus and literacy from non-FM patients (P = 0.01).
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Table 1. Tender Points Scores in Patients with Fibromyalgia, Osteoarthritis and Non-ostoearthritis
TPs score (kg/cm
2
) FM OA Non-OA
OA and non-OA 
(non-FM)
Difference in TP score 
between FM and non-FM
Low cervical 1.3 ± 0.4 1.7 ± 0.4 1.7 ± 0.5 1.7 ± 0.4 ‒0.4 ± ‒0.1
Second rib 2.0 ± 0.8 3.2 ± 0.8 2.9 ± 0.5 3.1 ± 0.7 ‒1.1 ± ‒0.3
Lateral epicondyle 2.4 ± 0.9 4.0 ± 0.9 3.9 ± 0.7 4.0 ± 0.8 ‒1.4 ± 0.2
Knee 2.5 ± 0.9 3.2 ± 1.2 3.7 ± 1.0 3.3 ± 1.1 ‒0.8 ± ‒0.1
Occiput 2.0 ± 0.8 3.0 ± 0.8 3.0 ± 0.6 3.0 ± 0.7 ‒1.0 ± 0.1
Trapezius 2.3 ± 0.9 3.8 ± 0.9 3.8 ± 0.9 3.8 ± 0.9 ‒1.5 ± ‒0.0
Supraspinatus 2.6 ± 0.9 4.1 ± 0.8 4.1 ± 1.0 4.1 ± 0.8 ‒1.4 ± ‒0.0
Gluteal 3.1 ± 0.9 4.4 ± 0.6 4.3 ± 0.9 4.4 ± 0.7 ‒1.3 ± ‒0.3
Greater trochanter 3.1 ± 0.8 4.4 ± 0.8 4.4 ± 0.9 4.4 ± 0.8 ‒1.2 ± ‒0.1
Values are presented as mean ± SD. P-values in all TP score differences between FM and non-FM were P ＜ 0.01. 
TP: tender point, FM: fibromyalgia, OA: osteoarthritis.
1. Tender points scores
Nine pairs of TPs in the same anatomical location on the 
right and the left side were highly correlated (R = 0.811; 
range: 0.74 to 0.86). Therefore, to avoid multicollinearity 
and to reduce the number of variables, data regarding the 
left and right sides were averaged to form nine variables. 
Table 1 shows the TPs scores of FM patients, OA and non- 
OA chronic pain disorder patients, as well as the combined 
OA with non-OA patients (non-FM patients). The last col-
umn (FM minus non-FM) illustrates items that are most 
discriminatory between FM and non-FM. The highest 
score differences belonged to the trapezius, supraspinatus, 
and lateral epicondyle area (＞ 1.4 kg/cm
2
) followed by the 
gluteal and greater trochanter area (1.2 kg/cm
2
). 
2. WPI and major FM symptoms
Similar to TPs scores, there were acceptable correlations 
between the left and the right pain locations in WPI (the 
jaw, shoulder girdle, upper arm, lower arm, hip, upper leg, 
and lower leg) (mean: R = 0.619; range: 0.51 to 0.75). There-
fore, the left and right side pain sites were merged to re-
duce the number of pain locations from 19 to 12. Table 2 
shows the percentages of FM, OA, and non-OA chronic 
pain patients as well as OA and non-OA patients combined 
(non-FM patients) in whom ACR 2011 criteria’s compo-
nents (12 pain locations and major FM symptoms) were 
present. We merged OA and non-OA groups into a single 
group (non-FM) to increase statistical power and permit 
regression and discriminant analyses.
3. FIQ scores
The FIQ scores of FM, OA, non-OA chronic pain patients, 
as well as the OA and non-OA patients combined were 
calculated. In the same classification criteria sets, the cal-
culated differences of the FIQ scores between FM and 
non-FM groups connoted the discriminatory properties of 
the FIQ items. The highest differences (≥ 0.7) between 
these two groups belonged to the following items: days 
feeling good, fatigue, and depression, all of which were 
worse in FM patients.
4. Variables predicting FM versus non-FM group mem-
bership
A preliminary standard multiple logistic regression analysis 
was performed with the 9 pairs of TPs scores, 12 pain 
sites, 6 major FM symptoms, and 20 FIQ items to identify 
variables uniquely and statistically associated with FM and 
non-FM group membership. We retained the variables with 
a P value less than 0.3 in order to prevent losing their 
possible contribution in the final analysis’ model. This 
analysis identified 20 significant variables: 4 TPs (lateral 
epicondyle, P = 0.07; knee, P = 0.21; second rib, P = 0.26; 
gluteal, P = 0.29), 6 pain locations (neck, P = 0.003; upper 
back, P = 0.004; shoulder, P = 0.016; hip, P = 0.01; abdo-
men, P = 0.24; lower leg, P = 0.034), 4 major FM symp-
toms (insomnia, P = 0.008; fatigue, P = 0.06; depression, 
P = 0.09; abdominal pain, P = 0.18), 6 FIQ items (physical 
function items [make beds, P = 0.25; drive a car, P = 0.29]; 
days feeling good, P = 0.15; work days missed, P = 0.25; 
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Table 2. American College of Rheumatology 2011 Classification Criteria Components’ Measures 
Variable FM OA Non-OA
OA and non-OA  
(non-FM)
Difference between 
FM and non-FM  
Pain location 　 　 　 　 　
Neck 77.2 16.0 23.8 17.7 59.5
Shoulder 79.5 18.7 23.8 19.8 59.7
Upper arm 51.5 6.7 19.0 9.4 42.1
Lower arm 48.0 9.3 38.1 15.6 32.4
Chest 29.2 4 14.3 6.3 22.9
Abdomen 18.7 1.3 0 1.0 17.7
Upper leg 39.2 9.3 19.0 11.5 27.7
Lower leg 62.6 64.0 47.6 60.4 2.2
Jaw 12.3 0 0 0 12.3
Upper back 58.5 6.7 14.3 8.3 50.2
Low back 59.1 16.0 14.3 15.6 43.5
Hip 52.6 8.0 4.8 7.3 45.3
Major FM symptom  　 　 　 　 　
Fatigue 2.0 ± 0.8 0.9 ± 0.9 0.8 ± 0.9 0.9 ± 0.9 1.1 ± ‒0.1
Waking unrefreshed 1.9 ± 0.8 0.8 ± 0.9 0.9 ± 1.0 0.8 ± 0.9 1.1 ± ‒0.1
Cognitive symptom  1.3 ± 0.8 0.6 ± 0.7 0.5 ± 0.5 0.5 ± 0.7 0.8 ± 0.1
Memory disturbance 81.3 46.6 52.4 47.9 33.4
Insomnia 82.6 40.5 19.0 35.0 63.6
Abdominal pain 55.8 28.0 42.9 31.3 12.9
Headache 82.6 45.3 33.3 42.7 49.3
Depression 87.8 40.5 33.3 38.9 54.5
Values are presented as percentage or mean ± SD. P-values in all percentages differences between FM and non-FM were P ＜ 0.01.
ACR: American College of Rheumatology, FM: fibromyalgia, OA: osteoarthritis.
fatigue, P = 0.02; depression, P = 0.01). 
These 20 variables were then entered into a stepwise 
multiple logistic regression analysis (Table 3) to identify 
variables that best differentiated the FM group from non- 
FM group. The analysis identified and ordered the 8 best 
discriminative variables according to their maximal stat-
istical contribution in predicting FM versus non-FM mem-
bership. This model with 8 predictors accounted for 64.8% 
of the variance associated with FM group membership 
(Table 3, column 3, bottom row). The most important pre-
dictors of group membership in order of magnitude were as 
follows (variance accounted for and FM vs. non- FM differ-
ences): lateral epicondyle TP (36.9%; 2.4 kg/cm
2
 vs. 4.0 
kg/cm
2
), neck pain (14.5%; 77.2% vs. 17.7%), fatigue (4.7%; 
2.0% vs. 0.9%), insomnia (3%; 82.6% vs. 35.0%), upper 
back pain (2.2%; 58.5% vs. 8.3%), shoulder pain (1.5%; 
79.5% vs. 19.8%) and gluteal TP (1.2%; 3.1 kg/cm
2
 vs. 4.4 
kg/cm
2
), FIQ fatigue (0.9%; 6.2 vs. 5.3).
Table 4 shows the unique contribution (partial correla-
tions) of each variable when other variables were controlled. 
The lateral epicondyle TP which was the first variable to 
be retained in the stepwise regression analysis had a 
strong, unique, and statistically significant partial correla-
tion (R = 0.220). Notably, insomnia and fatigue demon-
strated the strongest unique partial correlations (R = 0.271 
and 0.224, respectively) and also substantial zero-order 
correlations (R = 0.471 and 0.531, respectively). The FIQ 
fatigue item, which had a low FM/non-FM score differ-
ences, also had low zero-order and partial correlations 
(Table 4). 
Finally, discriminant function analysis was done to 
classify FM and non-FM individuals according to the final 
eight-variable list. Using this model, which we named the 
“combined FM model or C-FM model,” 91.4% of patients 
were correctly classified (Table 5). ROC curve analysis de-
termined the best cutoff point for the C-FM model. We 
found high sensitivity and specificity for this model (91.9% 
and 91.7%, respectively).
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Table 3. Stepwise Multiple Regression Analysis Showing 8  
Predictors Ranked in Order of Magnitude in Predicting Group 
Membership (FM or Non-FM)







Lateral epicondyle  
TP mean score
0.607 0.369 0.369 ＜ 0.01
Neck pain 0.717 0.514 0.145 ＜ 0.01
ACR 2011-fatigue 
score
0.749 0.560 0.047 ＜ 0.01
Insomnia 0.768 0.590 0.030 ＜ 0.01
Upper back pain 0.782 0.612 0.022 ＜ 0.01
Shoulder pain 0.792 0.627 0.015 ＜ 0.01
Gluteal TP mean 
score






The forward stepwise regression analysis used 8 predictors which
combined to produce a multiple R = 0.805 (last row, column 2). 
This accounted for 64.8% of variance associated with group mem -
bership (column 3). 
FM: fibromyalgia, TP: tender point, ACR: American College of 




 change represents prediction percentage of each variable in FM
membership. 
b
The forward stepwise regression analysis used 8 predictors which
combined to produce a multiple R = 0.805.
c
This accounted for 64.8% of variance associated with group 
membership.
Table 4. Zero Order (Pearson’s R) and Partial Correlations of Predictors in the Final Model 
Predictor Pearson’s R Partial R P value Odd ratio (95% CI)
Lateral epicondyle TP mean score ‒0.607 ‒0.220 ＜ 0.01 0.46 (0.2–0.8)
Neck pain 0.574 0.217 ＜ 0.01 3.1 (0.9–10.4)
ACR 2011-fatigue score 0.530 0.224 ＜ 0.01 3.0 (1.5–5.9)
Insomnia 0.471 0.271 ＜ 0.01 9.9 (2.9–33.8)
Upper back pain 0.490 0.201 ＜ 0.01 3.4 (0.9–12.4)
Shoulder pain 0.580 0.181 ＜ 0.01 2.2 (0.6–7.6)
Gluteal TP mean score ‒0.584 ‒0.172 ＜ 0.01 0.3 (1.0–0.6)
FIQ-fatigue score 0.151 0.16 ＜ 0.01 1.1 (0.9–1.3)
Minus correlation indicate that FM patients have lower scores on predictor variable. All Pearson’s correlations are significant. 
CI: confidence interval, TP: tender point, ACR: American College of Rheumatology, FIQ: fibromyalgia impact questionnaire.
Table 5. Correct Classification as Predicted by C-FM Model Using
8 Key Features
Variable





Non-FM 86 (89.6) 10 (10.4) 96
FM 13 (7.6) 159 (92.4) 172
Cross-validated
b
Non-FM 83 (86.5) 13 (13.5) 96
FM 14 (8.1) 158 (91.9) 172
FM: fibromyalgia, C-FM: combined FM.
a
91.4% of original grouped cases correctly classified. 
b
Cross vali-
dation is done only for those cases in the analysis. In cross vali-
dation, each case is classified by the functions derived from all 
cases other than that case. 89.9% of cross-validated grouped 
cases correctly classified.
DISCUSSION 
The analysis of 67 items derived from the ACR 1990 and 
2011 FM classification criteria and the FIQ identified the 
best constellation of key features of FM which can be use-
ful in FM diagnosis. We introduced the C-FM model which 
provides a practical diagnostic tool to accurately differ-
entiate FM among chronic pain disorders. Some valuable 
features from both sets of ACR criteria remained as the 
important discriminative features in the final model, but 
the FIQ components showed poor discriminatory properties 
in our analysis.
Given the fact that all the existing diagnostic classi-
fication criteria for FM have been faced with some chal-
lenges and impose some burden on physicians [5,17], de-
velopment of a combined model in order to address dis-
advantages of previous criteria seems essential. Exploring 
67 items taken from the 3 criteria sets to find the best 
discriminatory features of FM was the first attempt in this 
line. From a conceptual perspective, the combination of 
two TPs (lateral epicondyles and gluteal) and axial pain 
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(neck and upper back pain), along with fatigue and in-
somnia produced a substantial variance in group member-
ship (65%), with a correct classification rate of 91.4%. This 
study shows that all these predictors together can be con-
sidered as a valid model for the diagnosis of FM. Further-
more, unique contributions of these predictors were ap-
proximately equal in the classification of FM and non-FM 
patients (Table 4). According to this finding, it seems that 
the TPs, axial pain, fatigue, and insomnia which derived 
from the ACR 1990 and 2011 criteria play equal substantial 
roles when they are independently considered to differ-
entiate FM from non-FM patients. On the other hand, the 
FIQ components showed poor discriminatory properties in 
all the analyses. 
Lateral epicondyle TP, the first predictor in the C-FM 
model, was responsible for 36.9% of variance (Table 3). 
This indicates a unique role for this key feature in separat-
ing FM from other chronic pain disorders. This finding is 
contrary to the logics of elimination of TPs from the ACR 
2010 classification criteria which were the inherently arbi-
trary nature and low validation of TPs examination [6]. 
Although the ACR 2010 criteria study showed that muscle 
tenderness was one of the most important variables clas-
sifying cases and non-cases of FM, tenderness was not 
used in the final formulation of this criteria [6,10]. It is 
worthwhile to note that TPs have traditionally been thought 
as a clinical indicator of lowered pain thresholds [18]. 
Further, centrally mediated augmented pain and sensory 
processes have firmly been established to play a pivotal 
role in the hyperalgesia of FM patients [11,18]. Such a 
pathophysiological concept implicates that TPs could be 
used as an important and intuitive pointer of FM diagnosis 
[8]. So, it seems that TPs as a unique feature of hyper-
algesia in FM can still be saved for more valid diagnosis. 
Furthermore, our study showed that the examination 
of two TPs (lateral epicondyles and gluteal) would effi-
ciently differentiate FM from non-FM, especially if TPs are 
considered intimately with other major symptoms such as 
axial pain and fatigue. Undoubtedly, using fewer but more 
valid discriminatory TPs (examination of only 2 instead of 
9 TP pairs in the ACR 1990 criteria) can facilitate FM diag-
nosis by non-rheumatologic physicians and resolves the 
previous problems described with the ACR 1990 classi-
fication criteria. This is in line with previous studies dem-
onstrating that some TPs in fewer numbers might have 
more diagnostic value in differentiating FM from non-FM 
patients [14,19,20]. 
Another aspect of C-FM model is four components of 
the ACR 2011 criteria which have remained in this model. 
Interestingly, high axial pain including neck and high back 
pain showed substantial variance (14.5% and 2%, respect-
ively) in the group membership. It seems that axial pain 
plays more important role in discrimination of FM from 
non-FM rather than other pain locations [21]. These pre-
dictors along with fatigue and insomnia accounted for im-
portant contribution in FM membership. 
Fatigue, a cardinal symptom in FM, remained in two 
manners in the final model, either as an ACR 2011 criteria 
component or as a FIQ item. Actually, fatigue has been 
shown to be the second most reported symptom in fi-
bromyalgia [7,22]. Our findings are in agreement with such 
a general and consistent pattern of fatigue perception by 
FM patients. In fact, FIQ’s fatigue was the only item of 
FIQ in the current study that showed to have a discrim-
inatory property. On the other hand, other FIQ compo-
nents played a minimal role in differentiating FM from 
non-FM patients. 
The surprising notion was omission of other FM symp-
toms such as waking unrefreshed, cognitive and the so-
matic symptoms from the C-FM model, indicating the low 
discriminatory power of these variables. They constitute a 
pivotal portion of the ACR 2011 criteria, and the general 
knowledge supports their role in FM diagnosis. In our study, 
however, insomnia showed a better discriminatory prop-
erty than waking unrefreshed. The reason might be due 
to the difficult evaluation of waking unrefreshed rather 
than insomnia probably because the higher subjectivity 
nature of the former. Nonetheless, waking unrefreshed 
might still be considered as a surrogate marker for insom-
nia. Furthermore, cognitive dysfunction as another major 
component of the ACR 2011 classification criteria had a low 
discriminatory ability in our study. It concurs with the Tesio 
et al. [23] study in which different neuropsychological tests 
showed minor differences between FM and non-FM pa-
tients regarding cognitive function. Based on our study and 
previous literature [19,23] it seems that accepting cognitive 
function as a FM discriminatory feature still needs further 
investigation. 
To the best of our knowledge, this is the first study 
attempting to explore and combine the discriminative fea-
tures of both 1990 and 2011 versions of the ACR classi-
fication criteria. It seems that both classification criteria 
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have valuable key features whose combination can accu-
rately detect FM. Re-inclusion of an examination of fewer, 
but the most discriminative TPs, and decreased subjectivity 
in evaluation of FM are the strengths of the C-FM model. 
Although it is desirable for FM patients to be diagnosed 
and cared for by rheumatologists, in reality this is not al-
ways possible nor is necessary for most patients [24,25]. 
So, the simplicity and holistic nature of the C-FM model 
can facilitate diagnosis of FM patients in a realistic manner 
by physicians. 
Our study had some limitations. Only female patients 
were evaluated in this study and therefore the results of 
the study cannot be generalized to male patients with FM. 
Moreover, in this study, diagnosis of fibromyalgia was 
made based on expert opinion and clinical grounds, not on 
the ACR criteria. Although use of expert diagnosis as the 
gold standard for assessment of the discriminative ability 
of the existing ACR criteria items in FM diagnosis was in-
evitable, it remained a weak point of our study. Further-
more, we are not aware of the validity of the C- FM model 
in other populations and care settings. We think that the 
next step would be evaluation of the C-FM model’s validity 
in primary care setting as well as in patients with other 
rheumatic conditions. Finally, although the number of pa-
tients included in this study was relatively good, further 
studies with larger populations still need to be done to bet-
ter evaluate the diagnostic capabilities of the C-FM model. 
In summary, the C-FM model can accurately detect 
FM patients among other pain disorders by using fewer but 
more discriminative TPs along with high axial pain, fatigue, 
and insomnia. Using fewer discriminatory TPs can con-
serve the intuitive and unique hyperalgesia feature of FM. 
The combination of 8 key features derived from both the 
1990 and 2011 ACR criteria forming the C-FM model showed 
substantial discriminatory properties with a 91.4% correct 
classification rate. Re-inclusion of TPs and decreased 
subjectivity along with retaining FM’s main symptoms in 
the C-FM model can be considered a unique feature of this 
model. 
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